MedTrace Logo

Optimizing Prescribing of Antipsychotics in Long-Term Care

NCT03557593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-06-26

No results posted yet for this study

Summary

Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in LTC. A multi component intervention to reduce inappropriate antipsychotic prescribing was evaluated in ten Canadian long-term care facilities.

Conditions

Interventions

OTHER

Educational

Multi component educational intervention in long-term care

Sponsors & Collaborators

  • Canadian Consortium on Neurodegeneration in Aging

    collaborator OTHER

  • Canadian Frailty Network

    collaborator OTHER

  • Queen's University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-10-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03557593 on ClinicalTrials.gov